NN
Nilesh Namdev Auti
About Nilesh Namdev Auti
Data last updated:
Nilesh Namdev Auti is a Designated Partner at Nivian Pharma Llp (since 2021) and Director at Nivian Life Sciences Private Limited (since 2024). The companies operate in Pharma and Paper. The largest current company by reported revenue is Nivian Pharma Llp at ₹14.80 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nivian Pharma Llp AAN-0852 | Designated Partner | 23 Sep 2021 | 2018 | ₹14.80 Cr (FY 2023) | Active |
 Nivian Life Sciences Private Limited U21001MH2024PTC421643 | Director | 18 Mar 2024 | 2024 | Active |
Board colleagues of Nilesh Namdev Auti
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anjali Ajit Deval | 06701001 | Nivian Pharma Llp , Nivian Life Sciences Private Limited | Designated Partner |
| Kadayam Ramanathan Bharat | 00584367 | Nivian Life Sciences Private Limited | Additional Director |
| Mehernosh Framroze Daruwalla | 00520164 | Nivian Life Sciences Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nilesh Namdev Auti
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nilesh Namdev Auti
Nilesh Namdev Auti currently holds 2 directorships: Nivian Pharma Llp (Designated Partner, since 23 Sep 2021, revenue ₹14.80 Cr (FY 2023)); Nivian Life Sciences Private Limited (Director, since 18 Mar 2024).
Nilesh Namdev Auti was first appointed on 23 Sep 2021 as Designated Partner at Nivian Pharma Llp. The most recent appointment on record is 18 Mar 2024 at Nivian Life Sciences Private Limited.
The current boards of Nilesh Namdev Auti's companies include Anjali Ajit Deval (Nivian Pharma Llp), Kadayam Ramanathan Bharat (Nivian Life Sciences Private Limited), Mehernosh Framroze Daruwalla (Nivian Life Sciences Private Limited).